The Natural Killer (NK)-cell-activating receptor, CD160, is aberrantly expressed by CLL cells and other B-cell malignancies, but is not expressed by normal B-cells, making it a good target both diagnostically and for MRD analysis in CLL (18, 19). Here, CD160 is linked to B-cell chronic lymphocytic leukemia.